Literature DB >> 24656211

Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet.

Claude Steriade1, Danielle M Andrade2, Hanna Faghfoury3, Mark A Tarnopolsky4, Peter Tai2.   

Abstract

BACKGROUND: Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome can present management challenges. Refractory seizures and stroke-like episodes leading to disability are common. PATIENT: We analyzed the clinical, electrophysiologic, and radiologic data of a 22-year-old woman with multiple episodes of generalized and focal status epilepticus and migratory cortical stroke-like lesions who underwent muscle biopsy for mitochondrial genome sequencing.
RESULTS: Although initial mitochondrial genetic testing was negative, muscle biopsy demonstrated a mitochondrial DNA disease-causing mutation (m.3260A > G). New antiepileptic medications were added with each episode of focal status epilepticus with only temporary improvement, until a modified ketogenic diet and magnesium were introduced, leading to seizure freedom despite development of a new stroke-like lesion, and subsequent decrease in frequency of stroke-like episodes. We propose a metabolic model in which the ketogenic diet may lead to improvement of the function of respiratory chain complexes.
CONCLUSIONS: The ketogenic diet may lead to improvement of mitochondrial dysfunction in MELAS, which in turn may promote better seizure control and less frequent stroke-like episodes. Crown
Copyright © 2014. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MELAS; ketogenic diet; magnesium; refractory seizures; respiratory chain complexes; status epilepticus

Mesh:

Year:  2014        PMID: 24656211     DOI: 10.1016/j.pediatrneurol.2014.01.009

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  22 in total

Review 1.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 2.  The Relationship Between Headaches with Epileptic and Non-epileptic Seizures: a Narrative Review.

Authors:  William S Kingston; Todd J Schwedt
Journal:  Curr Pain Headache Rep       Date:  2017-03

Review 3.  Ketogenic diets in patients with inherited metabolic disorders.

Authors:  S Scholl-Bürgi; A Höller; K Pichler; M Michel; E Haberlandt; D Karall
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

Review 4.  Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.

Authors:  Kathryn M Camp; Danuta Krotoski; Melissa A Parisi; Katrina A Gwinn; Bruce H Cohen; Christine S Cox; Gregory M Enns; Marni J Falk; Amy C Goldstein; Rashmi Gopal-Srivastava; Gráinne S Gorman; Stephen P Hersh; Michio Hirano; Freddie Ann Hoffman; Amel Karaa; Erin L MacLeod; Robert McFarland; Charles Mohan; Andrew E Mulberg; Joanne C Odenkirchen; Sumit Parikh; Patricia J Rutherford; Shawne K Suggs-Anderson; W H Wilson Tang; Jerry Vockley; Lynne A Wolfe; Steven Yannicelli; Philip E Yeske; Paul M Coates
Journal:  Mol Genet Metab       Date:  2016-09-20       Impact factor: 4.797

5.  Nonsense and missense mutation of mitochondrial ND6 gene promotes cell migration and invasion in human lung adenocarcinoma.

Authors:  Yang Yuan; Weixing Wang; Huizhong Li; Yongwei Yu; Jin Tao; Shengdong Huang; Zhiyong Zeng
Journal:  BMC Cancer       Date:  2015-05-02       Impact factor: 4.430

6.  L-Arginine Affects Aerobic Capacity and Muscle Metabolism in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes) Syndrome.

Authors:  Lance H Rodan; Greg D Wells; Laura Banks; Sara Thompson; Jane E Schneiderman; Ingrid Tein
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

7.  Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Mol Genet Metab Rep       Date:  2016-12-23

8.  ND2 mutation with minimal coenzyme-Q responsive manifestations.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Mol Genet Metab Rep       Date:  2017-01-20

Review 9.  Mitochondrial disease: genetics and management.

Authors:  Yi Shiau Ng; Doug M Turnbull
Journal:  J Neurol       Date:  2015-08-28       Impact factor: 4.849

Review 10.  Ketogenic diet for mitochondrial disease: a systematic review on efficacy and safety.

Authors:  Heidi Zweers; Annemiek M J van Wegberg; Mirian C H Janssen; Saskia B Wortmann
Journal:  Orphanet J Rare Dis       Date:  2021-07-03       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.